Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at least 50 years old.
- People diagnosed with diabetes within the past 12 months, where there is a record of previously normal blood sugar levels within the past 2 years, and whose HbA1c (a blood sugar level measure) is 6.5% or above.
- People diagnosed with diabetes within the past 12 months, where there is no prior record of normal blood sugar levels, and whose HbA1c is 7.0% or above.
- People whose blood sugar levels have moved from the "pre-diabetes" range into the diabetes range within the past 12 months, shown by an HbA1c increase of 0.5% or more.
- People diagnosed with diabetes within the past 12 months who have exactly one first-degree relative (such as a parent or sibling) with diabetes, and whose HbA1c is 6.5% or above.
- People already diagnosed with diabetes whose HbA1c has risen by more than 2% within the past 6 months, confirmed by a repeat test, and where weight gain or missed diabetes medications are not the cause.
- People who are generally well or have only mild limitations in daily activity (confirm with trial site).
- People with no known reasons preventing them from having an MRI scan or receiving gadolinium contrast dye (a substance used during MRI scans).
- People willing to undergo MRI scanning and be checked for metal implants or metal-related injuries.
- People able to give informed consent to participate.
- People willing to return to the trial site for all required study visits.
Who may not be able to join:
- People with a previous diagnosis of pancreatic cancer.
- People who have or have had cancer that has spread to other parts of the body, or who have received additional cancer treatment (such as chemotherapy after surgery) within the past 5 years.
- People who have received chemotherapy within the past 6 months (hormonal therapy may be acceptable if the person has been cancer-free for at least 5 years — confirm with trial site).
- People with a hereditary condition causing recurring pancreatitis (inflammation of the pancreas).
- People who have used high-dose steroid medication (such as prednisone at 20 mg or more per day) within 3 months of their diabetes diagnosis or rise in HbA1c (lower doses may be considered on a case-by-case basis — confirm with trial site).
- People for whom MRI scanning or gadolinium contrast dye is not medically safe.
- People who are pregnant or breastfeeding.
- People with other serious health conditions that, in the treating clinician's judgement, would make participation in this trial unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard Frank, MD, Nuvance Health
Phone: 203-855-3551
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Early Stage Pancreatic Cancer or Precursor Lesions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.